26 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
immunotherapy, (ii) the 2018 Roche Agreement and 2017 Roche Agreement were not negotiated together as a package with a single commercial objective and (iii
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
targets in cancer immunotherapy, (ii) the 2018 Roche Agreement and 2017 Roche Agreement were not negotiated together as a package with a single
DEFA14A
SQZB
SQZ Biotechnologies Co
26 Apr 23
Additional proxy soliciting materials
4:31pm
. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
compensation package and further incentivizes our employees, including our named executive officers, in accordance with our compensation policies
DEFA14A
ak69qclxxbubqq5t
26 Apr 22
Additional proxy soliciting materials
5:08pm
8-K
EX-99.2
rpntuvldkfjs 6v
4 Jun 21
Regulation FD Disclosure
8:09am
DEFA14A
ctu4mrrtjww8o1
26 Apr 21
Additional proxy soliciting materials
5:10pm
DEF 14A
u7oie
26 Apr 21
Definitive proxy
5:00pm
10-K
b7err9kb
18 Mar 21
Annual report
6:31am
424B4
1tf4on 1wz2xerz5dc9
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
leynjrpfp8b3
1 Feb 21
Draft registration statement
12:00am
10-Q
ztm5d 4ktcven7wx
10 Dec 20
Quarterly report
4:46pm
424B4
qk5ec
30 Oct 20
Prospectus supplement with pricing info
4:54pm